Spain, France, Germany, and Italy reimburse darvadstrocel for perianal fistulae under national healthcare systems. Spain and Portugal additionally offer systemic MSC remission protocols with published outcome data. South Korea provides high-volume, cost-effective IBD cell therapy with rapid access. Belgium and the Netherlands operate specialised IBD cell therapy centres with robust follow-up. For EU fistula indication with reimbursement eligibility, French and German gastroenterology centres facilitate fastest pathway; for systemic remission, Spanish centres combine published evidence with reasonable cost.
Darvadstrocel for perianal fistulae costs approximately €7,000–9,500 per application in European centres. Systemic MSC induction therapy for active Crohn's or ulcerative colitis costs €6,000–8,000 per infusion protocol. Multiple fistulae or combined induction+maintenance regimens escalate costs to €12,000–20,000+ per year. Insurance coverage varies significantly: EU approved indication (perianal fistulae) is reimbursed by several national healthcare systems (Spain, France, Germany) with prior authorisation; systemic IBD remission therapy is rarely covered, classified as investigational. Out-of-pocket payment is standard for non-fistula indications.
Am I a candidate? → · Crohn's & IBD: full overview → · Crohn's & IBD cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
רפואה רגנרטיבית מאושרת GMP בלב האיחוד האירופי — החל מ-3,000–8,000 יורו, חלק קטן ממחירי ארהב או גרמניה. פרוטוקולים מותאמים אישית למטופלים מ-50+ מדינות.
בדיקה רפואית חינם